News and Updates
Find out what's happening in the area of Horizon Europe, Digital Europe and Horizon 2020
Science is wonderful! science fair 2025 call for ERC projects extended until 31 October
The ERC is looking for three ERC grantees to participate in the next edition of the ‘Science is Wonderful!’ fair which takes place in March 2025. This event is aimed at primary and secondary school students, and gives them the opportunity to interact with leading researchers and innovators through games, group experiments and quizzes.
More information on the Science is wonderful! science fair, the 2024 edition, what is in it for ERC grantees and what is expected from them, the evaluation criteria and the timeline is available in the application form for ERC grantees which is open until 31 October.
Related News
|
2024-11-05
|
2 weeks ago |
Evaluation results - ERC Synergy Grant 2024 call |
|
2024-10-24
|
4 weeks ago |
Inspiring science news from ERC grants |
|
2024-09-19
|
2 months ago |
Number of submitted proposals for ERC Proof of Concept Grant 2024 call – 2nd cut-off... |
|
2024-09-18
|
2 months ago |
Number of submitted proposals for ERC Advanced Grant 2024 call |
|
2024-09-06
|
2 months ago |
Evaluation results - ERC Starting Grant 2024 call |
|
2024-07-19
|
4 months ago |
Evaluation results – ERC Proof of Concept Grant 2024 call – 1st cut-off deadline 14 M... |
|
2024-07-12
|
4 months ago |
ERC 2025 work programme published |
|
2024-04-15
|
7 months ago |
Evaluation results - ERC Advanced Grant 2023 call |
myOVERVIEW
-
sign up for personalised information
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Latest News
1484 articles available search in articlesDeployment: Best use of technologies
Procurement: Better Internet for Kids (BIK) Platform – EU Coordination
The European Commission (DG CONNECT) has launched the following procurement procedure: Better Internet for Kids (BIK) Platform – EU Coordination (EC-CNECT/LUX/2024/OP/0097) The EU-funded Better Internet for Kids portal (at https://better-internet-for-kids.europa.eu) and the associated coordination tasks are the main subject of th... read more
Digital, Industry & Space AI, data & cloud
Commission consultation on AI Act prohibitions and AI system definition
The European Commission’s Artificial Intelligence (AI) Office has launched a targeted stakeholders consultation process on the future guidelines on the AI system definition and the implementation of AI practices that pose unacceptable risks under the AI Act. The guidelines will help national competent authorities as well as providers and dep... read more
Digital, Industry & Space AI, data & cloud
First draft of General-Purpose Artificial Intelligence Code of Practice
The European Commission has published the first draft of the General-Purpose Artificial Intelligence (AI) Code of Practice. The rules governing general-purpose AI models under the AI Act will come into application in August 2025. The Code of Practice aims to facilitate the proper implementation of these rules and will play a crucial role in guidin... read more
Testimonial
Methylomic – Hope & Improved outcomes for Crohn’s disease patients across Europe
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.
